Which antibiotic saves more burn patients from sepsis?
NCT ID NCT07096310
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study looks at two different antibiotic treatments for sepsis in burn patients. It compares a strong antibiotic called Meropenem with another called Pipracillin/Tazobactam to see which one helps more patients survive. The study involves 400 adults aged 21-60 with burns and sepsis. Researchers will check survival rates and also watch for a serious side effect called C. difficile infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University Hospitals
Cairo, 002, Egypt
Conditions
Explore the condition pages connected to this study.